apr
Excellence of Diabetes Research in Sweden (EXODIAB) minisymposium
Join the EXODIAB minisymposium for lectures on diabetes research. This event is aimed at anyone with an interest in diabetes research.
The minisymposium is arranged by researchers within the strategic research initiative EXODIAB (Excellence of Diabetes Research in Sweden). EXODIAB is a joint strategic research initiative in the diabetes area by Lund University and Uppsala University.
Programme
14.15-14.20 Welcome
Maria Gomez, Lund University
14.20-14.45 "PAX5 - a new player in T2D pathophysiology"
Karl Bacos, Lund University
14.45-15.10 "Metabolic signaling between organs in complex diseases"
Philipp Kaldis, Lund University
15.10-15.30 Coffe/tea
15.30-15.55 "VDAC1 as innate immunity executer gene in dysfunction of macrophages, endothelial and beta cells"
Tariq Mohammad, Lund University
15.55-16.20 "Differential impact of COVID-19 vaccination on symptom presentation during SARSCoV-2 infection and long-COVID depending on BMI and diabetes"
Hugo Fitipaldi, Lund University
16.20-16.45 "Clusters of eGFR trajectories after diabetes diagnosis in ANDIS"
Daniel Coral, Lund University
16.45-17.10 "Prognostic imaging biomarkers for DKD: iBEAt study"
Maria Gomez, Lund University
17.10 Continued discussions, drinks and snacks in the lunch room area, 91:11
Join the minisymposium at CRC in Malmö or online via Zoom: https://lu-se.zoom.us/j/66345469812
Om evenemanget
Plats:
Agardh lecture hall, CRC, Jan Waldenströms gata 35, SUS Malmö
Kontakt:
ulrika [dot] blom-nilsson [at] med [dot] lu [dot] se